Huron Recognized as a 2025 ‘Best Place to Work' by Glassdoor
CHICAGO, January 29, 2025--(BUSINESS WIRE)--Global professional services firm Huron (NASDAQ: HURN) has been named a 2025 'Best Place to Work' by Glassdoor, one of the world's largest and most influential platforms for workplace insights. For the second year in a row Huron secured a position on Glassdoor's Best Places to Work US Large list, achieving a 4.3-star rating based on employee feedback.
"This recognition from Glassdoor is especially meaningful because it reflects the experiences and feedback of our employees," said Kristen Bruner, Chief Human Resources Officer of Huron. "At Huron, we believe that investing in our people is one of the most important things we can do. Whether through opportunities for professional growth, fostering a culture of inclusion and belonging, or supporting individual well-being, we are committed to helping our people thrive. This award inspires us to continue to create an environment where every person can reach their full potential."
Glassdoor's Employees Choice Award winners for the Best Places to Work 2025 are determined using its proprietary awards algorithm. Each employer's rating is determined based on the quantity, quality and consistency of Glassdoor-approved company reviews submitted by U.S.-based employees between Oct. 17, 2023 and Oct. 16, 2024. During the year-long eligibility period, employers considered for the large list must receive at least 75 ratings for each of Glassdoor's nine workplace attributes.
At Huron, we see what's possible in you and help you achieve it. Explore our open roles here.
ABOUT HURON
Huron is a global professional services firm that collaborates with clients to put possible into practice by creating sound strategies, optimizing operations, accelerating digital transformation, and empowering businesses and their people to own their future. By embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve. Learn more at www.huronconsultinggroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250129423583/en/
Contacts
MEDIA CONTACT Allie Bovisabovis@hcg.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
15 minutes ago
- Associated Press
LINE LOSS ALERT: Lineage, Inc. Investors with Losses are Reminded of the September 30 Class Action Deadline – Contact BFA Law (NASDAQ:LINE)
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company's senior executives and directors for potential violations of the federal securities laws. If you invested in Lineage, you are encouraged to obtain additional information by visiting: Investors have until September 30, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 11 and 15 of the Securities Act of 1933 on behalf of investors who purchased stock pursuant and/or traceable to Lineage's registration statement for its initial public offering held on or about July 25, 2024. The case is pending in the U.S. District Court for the Eastern District of Michigan and is captioned City of St. Clair Shores Police and Fire Retirement System v. Lineage, Inc., et al., No. 2:25-cv-12383. Why Was Lineage Sued Under the Federal Securities Laws? Lineage is a cold storage focused real estate investment trust ('REIT'). Through its Global Warehousing Segment, Lineage owns and operates hundreds of temperature-controlled storage facilities used by companies to store food and other perishable products. As alleged, Lineage's IPO documents touted its 'consistent cold chain demand,' which purportedly provided Lineage 'with strong cash flows even during periods of broader economic stress.' The IPO documents also represented that the lingering effects of the COVID-19 pandemic had 'accelerated trends that . . . have the potential to be growth engines for the industry in coming years.' In truth, Lineage was allegedly in the midst of a sustained downturn, as its customers destocked excess inventory built up during the COVID-19 pandemic, and also shifted to leaner inventories on a go-forward basis and as more cold-storage supply came on line. Events Following the IPO On February 26, 2025, Lineage announced its fiscal Q4 2024 financial results, revealing that customers had been 'unwinding' previously 'overbuil[t]' levels of inventory, returning to a 'more normal seasonal pattern' that was expected to 'continue moving forward.' Lineage conducted its IPO at $78 per share. Since the IPO, the price of Lineage stock has fallen dramatically, to lows near $40 per share—approximately half the IPO price. Click here for more information: What Can You Do? If you invested in Lineage you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact: Ross Shikowitz [email protected] 212.789.3619 Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.
Forbes
15 minutes ago
- Forbes
7 Passive Income Ideas For Busy Professionals In 2025
What does it mean to be wealthy in America? The answer depends on where you live. Ask a professional in New York City, one of the nation's most expensive metros. I put the question to Janel Abrahami, a Glassdoor career expert, and she told me that even a salary of $150,000 in the New York Metropolitan area is fairly modest and just barely scratching the surface of paying the bills. 'It seems so shocking and wild to get to this place where that does not feel like nearly enough to achieve the American dream,' she expressed. (At the same time, salaries in NYC are generally higher than other locales, just like in California.) So how do you close the gap on the cost/salary discrepancy without quitting your job? The answer: passive income. 7 AI-Powered Passive Income Ideas For Busy Professionals And thanks to AI tools like ChatGPT, it's become faster and easier than ever to build, launch, and promote your passive income idea, and make money within days or weeks at most, without sacrificing too much time or needing to leave your job. Here are seven passive income ideas that are AI-powered and are perfect for busy professionals: How Do I Make Passive Income While Working Full-Time? Follow the advice in this article and try any of the ideas above. The initial legwork will be challenging, but once you begin to scale and see your income compound and even double your salary, it will be so worth it. Once you've begun to see success with one stream of passive income, diversify and consider branching out and building on this success by creating other, complementary, passive income sources. Even though a single paycheck is scarcely enough to keep up with the cost of living and supporting yourself and your family comfortably, the passive income ideas in this article prove that when you employ the right AI tools and think strategically, you can generate extra cash without quitting your job or taking up a second one. If you found this article incredibly helpful, you should check out 11 Must-Try AI Tools For Freelancers In 2025 next.
Associated Press
15 minutes ago
- Associated Press
RXST LOSS ALERT: RxSight, Inc. Investors with Losses are Reminded of the September 22 Class Action Deadline – Contact BFA Law (NASDAQ:RXST)
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: Investors have until September 22, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased RxSight securities. The case is pending in the U.S. District Court for the Central District of California and is captioned Makaveev v. RxSight, Inc., et al., No. 25-cv- 01596. Why Was RxSight Sued for Securities Fraud? RxSight is engaged in the manufacture and sale of light adjustable intraocular lenses used in cataract surgery along with capital equipment used with the lenses. The Company's main product is its Light Adjustable Lens (LAL) that can be customized after cataract surgery through a series of non-invasive light treatments. These treatments, using a Light Delivery Device (LDD), adjust the lens's shape and power to optimize vision based on the patient's individual needs and preferences. During the relevant period, the Company touted its strong LAL and LDD sales and failed to disclose 'adoption challenges' in its products. In reality, RxSight was experiencing a slowdown in LAL utilization that was first noted in 2024. The Stock Declines as the Truth Is Revealed On April 3, 2025, before the market opened, RxSight cut its 2025 full-year revenue forecast citing a 'softening' of the market that purportedly occurred 'in the second half of 2024.' On this news, the price of RxSight stock declined roughly 38%, from $26.12 per share on April 2, 2025, to $16.21 per share on April 3, 2025. Then on July 8, 2025, the Company further cut its 2025 full-year revenue forecast. RxSight attributed the adjustment to 'the slower ramp in LAL utilization that was first noted in 2024' and '[a]doption challenges over the last few quarters.' On this news, the price of RxSight stock declined roughly 38%, from $12.79 per share on July 8, 2025, to $7.95 per share on July 9, 2025. Click here for more information: What Can You Do? If you invested in RxSight you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact: Ross Shikowitz [email protected] 212.789.3619 Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.
